Behavioral Health Business March 7, 2025
This is an exclusive BHB+ story
Often hailed as a miracle drug, GLP-1 medications have been used to treat everything from diabetes to substance use disorders. But now an unlikely group of providers might be incorporating these medications into care.
Eating disorder providers are exploring their potential to help patients with binge eating and bulimia nervosa—marking a significant shift in a field traditionally cautious about medication interventions.
Still, GLP-1s have historically troubled eating disorder treatment experts, who have expressed concerns that the drugs could worsen or re-trigger eating disorders.
And while major players in the industry are excited about potential new treatments for eating disorders, many remain relatively wary of GLP-1s as treatment tools and await more substantial data. If...
Today's Sponsors
Today's Sponsor